Patents Assigned to Roche Diabetes Care, Inc.
  • Patent number: 11533166
    Abstract: A method for controlling distribution of a product in a computer network is provided, comprising: providing a computer network having a plurality of processing devices each comprising one or more processors and a storage; and providing keys for asymmetric cryptography in the computer network. In a first data processing device assigned to the manufacturer in the computer network, the following is provided: generating a matrix code by encoding first electronic information comprising the private product key; providing the public product key, the public manufacturer key, and the private manufacturer key; generating a first transaction assigned to the product, a first transaction content of the first transaction comprising the public product key, and the public manufacturer key; and signing the first transaction with both the private product key and the private manufacturer key. Imprint data are provided for imprinting an imprint of the matrix code on the product. Further, a system is provided.
    Type: Grant
    Filed: July 31, 2020
    Date of Patent: December 20, 2022
    Assignee: Roche Diabetes Care, Inc.
    Inventor: Christoph John
  • Patent number: 11532826
    Abstract: A method for operating a medical device includes activating a processor in the medical device in a low-power operating mode, measuring a first voltage level of the battery, applying at least one discharge pulse to the battery in response to the first voltage level of the battery being greater than a predetermined passivation minimum voltage threshold and less than a predetermined passivation maximum voltage threshold, measuring a second voltage level of the battery after the at least one discharge pulse, and operating the processor in the medical device in an increased-power operating mode to continue operation of the medical device only in response to the second voltage level being greater than or equal to a predetermined operating voltage threshold, the predetermined operating voltage threshold being greater than the predetermined passivation minimum voltage threshold and less than or equal to the predetermined passivation maximum voltage threshold.
    Type: Grant
    Filed: December 19, 2019
    Date of Patent: December 20, 2022
    Assignee: Roche Diabetes Care, Inc.
    Inventors: Larry Lewis Lockridge, Duane Patrick Fridley, Kurt Gerard Klem, Michael Joseph Blackburn, Nathan Eugene Manlove, Steven Kent Moore, Marshall M. Parker
  • Patent number: 11510601
    Abstract: A sensor (110), a sensor assembly (256) for detecting at least one analyte in a body fluid and methods of manufacturing a sensor (110) and a sensor assembly (256) for detecting at least one analyte in a body fluid are disclosed. The sensor (110) has at least one substrate (114). The sensor (110) further has at least two electrodes (116) applied to the substrate (114), wherein the electrodes (116) are adapted for detecting the analyte. The sensor (110) further has at least two contact pads (118) applied to the substrate (114) and at least two electrical traces (120) applied to the substrate (114). The electrical traces (120) electrically connect the electrodes (116) and the contact pads (118). The sensor (110) further comprises a sealing ring (134) fixedly applied to the substrate (114). The sealing ring (134) surrounds the contact pads (118).
    Type: Grant
    Filed: November 18, 2016
    Date of Patent: November 29, 2022
    Assignee: ROCHE DIABETES CARE, INC.
    Inventor: Herbert Harttig
  • Patent number: 11510595
    Abstract: An implantable sensor can be used for determining a concentration of at least one analyte in a medium, particularly in a body tissue and/or a body fluid. The implantable sensor can comprise a flexible, tubular sensor element. This sensor element has a tubular body on which at least two electrode rings are mounted for electrochemical determination of the concentration of the analyte.
    Type: Grant
    Filed: November 3, 2009
    Date of Patent: November 29, 2022
    Assignee: Roche Diabetes Care, Inc.
    Inventors: Karin Schwind, Hans-Peter Haar, Otto Fuerst
  • Publication number: 20220354396
    Abstract: A volumetric sampling apparatus for volatile compounds comprises a structure, such as a channel structure that forms a continuous curve between the inlet port and the outlet port. A gas flow induced in the structure urges volatile compounds collected via transdermal diffusion toward the outlet port, where the volatile compounds may be collected and analyzed by a gas composition analyzer coupled to the outlet port.
    Type: Application
    Filed: July 26, 2022
    Publication date: November 10, 2022
    Applicant: Roche Diabetes Care, Inc.
    Inventors: HERBERT FINK, HANS LIST, ALPESHKUMAR KACHHADIA
  • Patent number: 11494172
    Abstract: A method for monitoring medical data is disclosed, the method being applicable to a system comprising a portable medical device, a mobile communications device, and, optionally, a medical care server. The portable medical device and the mobile communications device each comprise at least one interface for data transfer. The method comprises a step of establishing a download link between the mobile communications device and a download server. The method comprises a step of selecting an appropriate communication software package from a plurality of communication software packages for controlling data transfer between the mobile communications device and the portable medical device from the download server. Further, the method comprises a download step for downloading communication software package from the download server to the mobile communications device and a step of installation of the communication software package on the mobile communications device.
    Type: Grant
    Filed: June 1, 2022
    Date of Patent: November 8, 2022
    Assignee: Roche Diabetes Care, Inc.
    Inventors: Christoph Cronrath, Fernando Andreu, Alberto Val Vicente
  • Patent number: 11493473
    Abstract: A method and system for determining a failsafe value for a biosensor having two perimeter electrodes, a distal electrode, and a proximal electrode are disclosed. A liquid measuring medium is applied to a capillary channel of the biosensor. The method includes applying an alternating voltage to the perimeter electrode and the proximal electrode, measuring conductivity to determine a first impedance between the perimeter electrode and the proximal electrode, applying the alternating voltage to the perimeter electrode and the distal electrode, measuring conductivity to determine a second impedance between the perimeter electrode and the distal electrode, determining a value using the first impedance and the second impedance, and providing an error message to the user if the value is out of tolerance. If the value is out of tolerance, then defects or breaks in the electrodes and/or reagent in a reaction area are present and the method disallows the test result.
    Type: Grant
    Filed: June 6, 2018
    Date of Patent: November 8, 2022
    Assignee: ROCHE DIABETES CARE, INC.
    Inventors: Terry A. Beaty, Michael Harrison Wheeler
  • Patent number: 11488710
    Abstract: A method for controlling operation of a medical device in a medical system having a medical device, a communication device including a remote control for the medical device, and a safety device adapted for data communication with the communication device. Input data is provided and processed by a first calculation to thereby provide a first calculation result. The input data is processed by a second calculation executed separately from first calculation to thereby provide a second calculation result. The first and second calculation results are compared. When the first and second calculation results are found equal, remote control of the medical device by a medical device application running on the communication device is allowed. When the first and second calculation results are found not equal, the medical device application running on the communication device for remote control of the medical device is prevented.
    Type: Grant
    Filed: May 15, 2020
    Date of Patent: November 1, 2022
    Assignee: Roche Diabetes Care, Inc.
    Inventors: Kurt Friedli, Michael Mueller, Nils Danckwardt
  • Publication number: 20220323676
    Abstract: A computer-implemented diabetes management method includes a first determination of an insulin bolus related to one or more obtained glucose values and optionally the expected carbohydrate content of a meal to be ingested, a re-calculation of an insulin bolus in consideration of a user's body parameter information as measured by a body-worn sensor, providing a notification to the user if there is a significant deviation between the two calculated bolus amounts, and a user input whether the calculated insulin bolus or the re-calculated insulin bolus is selected by the user for bolus administration.
    Type: Application
    Filed: June 28, 2022
    Publication date: October 13, 2022
    Applicant: Roche Diabetes Care, Inc.
    Inventors: David Christopher Krey, Hans-Juergen Kuhr
  • Publication number: 20220304763
    Abstract: This disclosure is directed to a disposal container system enabling storage of used or contaminated articles having a generally flat, strip-shaped configuration, such as diagnostic biosensors. The disposal container is removably mountable to a supply container, and has an insertion portion provided in a wall of the disposal container. The insertion portion has a contour configured externally to guide deposit of a flat, strip-shaped article through a narrow slit, the contour further configured internally to deflect any loose articles in the interior space of the disposal container away from any accidental alignment with the slit which would cause free extraction of the articles. The disposal container may be configured for engagement with a supply container, such as a round or non-round vial, in a bottom-cap configuration or in a side-by-side configuration, by way of an engagement portion.
    Type: Application
    Filed: June 16, 2022
    Publication date: September 29, 2022
    Applicant: Roche Diabetes Care, Inc.
    Inventors: Michel Alain Jean Marie Cadio, Ernest Graeme Harvey, Justin David Adams, Vijay Thambiah
  • Patent number: 11446436
    Abstract: Disclosed is a flow detector (1) for releasable coupling with a flow channel (20) in a channel coupling area and detecting a flow of liquid drug in the flow channel (20), the flow detector including: an upstream thermoelectric element (10a) and a downstream thermoelectric element (10b), wherein the upstream thermoelectric element (10a) and the downstream thermoelectric element (10b) are arranged spaced apart from each other and movable independent from each other; an upstream biasing element (15a) and a downstream biasing element (15b), wherein the upstream biasing element (15a) acts on the upstream thermoelectric element (10a), thereby biasing the upstream thermoelectric element (10a) towards the channel coupling area, and the downstream biasing element (15b) acts on the downstream thermoelectric element (10b), thereby biasing the downstream thermoelectric element (10b) towards the channel coupling area independently from the upstream biasing element (15a).
    Type: Grant
    Filed: July 6, 2017
    Date of Patent: September 20, 2022
    Assignee: ROCHE DIABETES CARE, INC.
    Inventors: Hans List, Frederic Wehowski
  • Patent number: 11448674
    Abstract: An analyte test meter that detects contact between a user and an electrochemical test strip includes a test strip port, a capacitive sensor positioned proximate to the test strip port, and a controller connected to the test strip port and the capacitive sensor. The controller is configured to identify insertion of the electrochemical test strip into the test strip port, apply a drive signal to the capacitive sensor, measure a first response to the drive signal from the capacitive sensor, identify dosing of a fluid sample on the electrochemical test strip, apply the drive signal to the capacitive sensor after the dosing, measure a second response to the drive signal from the capacitive sensor, and detect contact between a body of a user and at least one electrode in the electrochemical test strip in response to a difference between the first and second responses exceeding a predetermined threshold.
    Type: Grant
    Filed: October 4, 2019
    Date of Patent: September 20, 2022
    Assignee: Roche Diabetes Care, Inc.
    Inventor: Michael J. Celentano
  • Publication number: 20220287563
    Abstract: Embodiments related to a self-administered, behavior modification program facilitated through a structured tailoring method and system thereof which accelerates and enhances the internalization process of the individual, and which provides help when the individual begins to fail in adhering or continuing with the behavior modification are disclosed. Program instructions that when executed by a processor causes a processor to initiate automatically a schedule of events of a structured tailoring procedure upon entry criteria being met at some unknown time, provide intervention according to the intervention preferences when the adherence criteria for one of the events has not been met, and end automatically the structured collection procedure upon exit criteria being met at some unknown time.
    Type: Application
    Filed: June 2, 2022
    Publication date: September 15, 2022
    Applicant: Roche Diabetes Care, Inc.
    Inventors: Daniel Wong, David Hasker, Glenn Brassington, Stefan Weinert, Abhishek S. Soni, Alan Greenburg, Paul J. Galley, Ulrich Porsch, Robert E. Reinke, Marco De Polo
  • Patent number: 11433182
    Abstract: A drug delivery device comprises first and second liquid drug reservoirs and first and second outlet ports. A drive is configured for expelling a first liquid drug from the first reservoir to the first outlet port and for expelling a second liquid drug from the second reservoir to the second outlet port. A memory is provided that contains a drug dosing scheme specifying a desired liquid drug type, and at least one sensor is provided that detects information concerning the type of liquid drug contained in the first and/or second reservoir. A processor receives the information from the at least one sensor and thereby determines the type of liquid drug retained in the first reservoir and/or the second reservoir, and uses the drug dosing scheme and the determined type of liquid drug to operate the drive. Associated devices this disclosure and methods are also disclosed.
    Type: Grant
    Filed: May 24, 2019
    Date of Patent: September 6, 2022
    Assignee: Roche Diabetes Care, Inc.
    Inventors: Frank Deck, Hans List
  • Patent number: 11426518
    Abstract: An inventive drug delivery system includes a reservoir that holds a drug to be administered. A drug applicator injects or infuses the drug, and a pump generates a flow of the drug from the reservoir to the drug applicator. A control system has a pressure sensor that measures pressure signals indicative of resistance against the flow of the drug and a processor is in communication with the pressure sensor. The control system detects with the pressure sensor a pressure signal indicative of the resistance against the flow of the drug while the drug is being administered and compares the measured pressure signal to a reference value. The control system also generates display data and provides it to an output device when the measured pressure signal exceeds the reference value. The display data includes a scheduled test reminder for a glucose level test that is communicated to an output device.
    Type: Grant
    Filed: June 5, 2020
    Date of Patent: August 30, 2022
    Assignee: Roche Diabetes Care, Inc.
    Inventors: Alexander Licht, Tobias Kuhn-Ullrich
  • Patent number: 11426248
    Abstract: A functional medical package is disclosed having a disposable package and a sterile container removably received inside the disposable package. A subsystem is received in the sterile container and is configured to be at least partially inserted into a host. The sterile container has an insertion exit opening for the subsystem and a liner closes the insertion exit opening. The liner is attached to the disposable package and automatically peels off the insertion exit opening when the sterile container is removed from the disposable package. Also disclosed are a method of manufacturing the medical package and a method of using the medical package with an inserter.
    Type: Grant
    Filed: July 27, 2018
    Date of Patent: August 30, 2022
    Assignee: Roche Diabetes Care, Inc.
    Inventor: Frank Deck
  • Patent number: 11419790
    Abstract: A transfer station for transferring a medical fluid between at least one supply container and at least one administration container of an infusion device is described. In an embodiment, the transfer station comprises at least one supply port configured for fluidic connection of the at least one supply container to the transfer station, and at least one exit port configured for fluidic connection of the at least one administration container to the transfer station. A transfer mechanism for automatically transferring a predetermined amount of medical fluid from the at least one supply container to the at least one administration container, and an electronic processing unit connected to an actuation means are provided with the transfer station. A processing unit controls the transfer mechanism and fluid transfer conditions according to a predetermined transfer demand entered by the actuation means.
    Type: Grant
    Filed: February 11, 2015
    Date of Patent: August 23, 2022
    Assignee: ROCHE DIABETES CARE, INC.
    Inventors: Ofer Yodfat, Illai J Gescheit, Iddo M. Gescheit
  • Publication number: 20220257117
    Abstract: An ambulatory medical device and a method of communication between medical devices are disclosed. In one embodiment, the medical device includes a module for communication with at least a second medical device wherein the module for communication is adapted to be activated by a value of a physiological parameter of an animal. In one embodiment, the method of the present invention involves a first medical device and at least a second medical device wherein the communication between said medical devices is activated by a value of a physiological parameter of an animal.
    Type: Application
    Filed: May 3, 2022
    Publication date: August 18, 2022
    Applicant: ROCHE DIABETES CARE, INC.
    Inventors: Matthias Essenpreis, Ulrich Haueter, Nicole Bernini, Sybille Fankhauser, Sebastiaan La Bastide, Gunnar Meyer Olden, Michael Schoemaker, Kelly Heaton, Joel Jeckelmann
  • Publication number: 20220257118
    Abstract: Embodiments related to a system and method managing the implementation, execution, data collection, data analysis and status reporting of a structured collection procedure running on a portable, hand-held collection device are disclosed. The collection device performing the structured collection procedure has program instructions that when executed by a processor cause the processor to initiate automatically a schedule of events of the structured collection procedure upon one or more entry criteria being met at some unknown time, store in memory patient data collected in accordance to the schedule of events, end automatically the structured collection procedure upon one or more exit criteria being met at some unknown time. Status reporting can be provided throughout the execution of the collection procedure.
    Type: Application
    Filed: May 6, 2022
    Publication date: August 18, 2022
    Applicant: Roche Diabetes Care, Inc.
    Inventors: Abhishek S. Soni, Paul J. Galley, Alan Greenburg, Steven Bousamra, Stefan Weinert, Erica Diebold
  • Patent number: 11406759
    Abstract: A method for connecting a force sensor to a circuit board is disclosed. A circuit board having first and second conductive leads located on the same surface of the circuit board is provided. Also provided is a force sensor with a first flexible contact tab having a first contact pad and a second flexible contact tab having a second contact pad. The first contact pad is arranged to face the first conductive lead. A first conductive rubber element establishes an electrical connection between the first contact pad and the first conductive lead, and the second contact pad and the second conductive lead are arranged to face in the same direction. A second conductive rubber element establishes an electrical connection between the second contact pad and the second conductive lead. Also disclosed are an associated device for determining fluid pressure in an insulin pump and an insulin pump.
    Type: Grant
    Filed: March 25, 2019
    Date of Patent: August 9, 2022
    Assignee: Roche Diabetes Care, Inc.
    Inventor: Hans List